Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by diadon1945on Feb 12, 2008 1:10am
257 Views
Post# 14354758

RE: Bellini bought 300,000 shares at 31 cents....

RE: Bellini bought 300,000 shares at 31 cents....You are right NRM has the money..and Bellini himself has even more money! He also has the expertise in Alzheimers. A partnership between NRM and SSS on Alzheimers makes sense. And we know from the SSS CEO that they have had some talks with BioMS on the MS indication and BioMS has over $120 million in cash and another $400 million in staged payments coming....so there is a possible MS partnership. And the CEO said they had some talks last year with Japanese and Korean firms on the Stroke program. There are very high stroke rates in those countries. So I can see some regional partnerships on the near horizon. But then of course maybe Bellini or someone else will come along to pick up the whole company at this early stage...I expect many shareholders would take $5 a share now rather than $100 a share 4 years from now!
Bullboard Posts